DEFB128
gene geneOn this page
Also known as DEFB-28
Summary
DEFB128 (defensin beta 128, HGNC:18106) is a protein-coding gene on chromosome 20p13, encoding Beta-defensin 128 (Q7Z7B8). Has antibacterial activity.
Defensins are cysteine-rich cationic polypeptides that are important in the immunologic response to invading microorganisms. The antimicrobial protein encoded by this gene is secreted and is a member of the beta defensin protein family. Beta defensin genes are found in several clusters throughout the genome, with this gene mapping to a cluster at 20p13.
Source: NCBI Gene 245939 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 17 total
- MANE Select transcript:
NM_001037732
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18106 |
| Approved symbol | DEFB128 |
| Name | defensin beta 128 |
| Location | 20p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-28 |
| Ensembl gene | ENSG00000185982 |
| Ensembl biotype | protein_coding |
| Entrez | 245939 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000334391
RefSeq mRNA: 1 — MANE Select: NM_001037732
NM_001037732
CCDS: CCDS33430
Canonical transcript exons
ENST00000334391 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001336348 | 187853 | 188118 |
| ENSE00001336349 | 189575 | 189711 |
Expression profiles
Bgee: expression breadth broad, 12 present calls, max score 50.67.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0536 / max 97.1203, expressed in 1 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185954 | 0.0462 | 1 |
| 185953 | 0.0073 | 1 |
Top tissues by expression
121 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| granulocyte | CL:0000094 | 50.67 | silver quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| leukocyte | CL:0000738 | 29.79 | silver quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| monocyte | CL:0000576 | 28.86 | silver quality |
| urinary bladder | UBERON:0001255 | 28.29 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| muscle of leg | UBERON:0001383 | 24.96 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| pancreas | UBERON:0001264 | 24.26 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| frontal cortex | UBERON:0001870 | 23.95 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- The protein encoded by this gene is thought to display antimicrobial activity. (PMID:12620395)
- This aim of this study was to identify novel biomarkers using comparative global proteome analysis to improve the risk assessment for recurrent coronary events. Beta -defensin-128 and histatin-3 may be potential biomarkers whch may be used to improve risk the stratification for recurrent coronary events. (PMID:28627688)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb20 | ENSMUSG00000049560 |
| rattus_norvegicus | Defb20 | ENSRNOG00000023384 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB116 (ENSG00000215545), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 128 — Q7Z7B8 (reviewed: Q7Z7B8)
Alternative names: Beta-defensin 28, Defensin, beta 128
All UniProt accessions (1): Q7Z7B8
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001032821* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
| IPR050544 | Beta-defensin | Family |
Pfam: PF13841
UniProt features (6 total): disulfide bond 3, signal peptide 1, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z7B8-F1 | 69.47 | 0.02 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 24–52, 32–46, 36–53
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 15 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM, GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_CELL_KILLING, GOBP_RESPONSE_TO_BACTERIUM, REACTOME_ANTIMICROBIAL_PEPTIDES, METTL14_TARGET_GENES, chr20p13, HBZ_TARGET_GENES, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM, REACTOME_DEFENSINS, REACTOME_BETA_DEFENSINS
GO Biological Process (6): killing of cells of another organism (GO:0031640), innate immune response (GO:0045087), defense response to Gram-negative bacterium (GO:0050829), defense response to Gram-positive bacterium (GO:0050830), defense response (GO:0006952), defense response to bacterium (GO:0042742)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response to bacterium | 2 |
| cell killing | 1 |
| disruption of cell in another organism | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| response to stress | 1 |
| defense response | 1 |
| response to bacterium | 1 |
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
204 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB128 | DEFB125 | Q8N687 | 834 |
| DEFB128 | DEFB124 | Q8NES8 | 802 |
| DEFB128 | DEFB135 | Q30KP9 | 769 |
| DEFB128 | DEFB134 | Q4QY38 | 699 |
| DEFB128 | DEFB129 | Q9H1M3 | 656 |
| DEFB128 | DEFB126 | Q9BYW3 | 640 |
| DEFB128 | DEFB132 | Q7Z7B7 | 621 |
| DEFB128 | DEFB114 | Q30KQ6 | 592 |
| DEFB128 | DEFB116 | Q30KQ4 | 561 |
| DEFB128 | DEFB123 | Q8N688 | 511 |
| DEFB128 | DEFB131A | P59861 | 507 |
| DEFB128 | LCN9 | Q8WX39 | 506 |
| DEFB128 | DEFB110 | Q30KQ9 | 477 |
| DEFB128 | CST11 | Q9H112 | 473 |
| DEFB128 | BPIFC | Q8NFQ6 | 471 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM209A | DEFB128 | psi-mi:“MI:0915”(physical association) | 0.560 |
| DEFB128 | FAM209A | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (1): DEFB128 (Two-hybrid)
ESM2 similar proteins: A2A5H7, A4H202, A4H203, A4H204, A4H225, A4H226, A4H227, A4H228, A4H253, A4H254, A4H255, P50704, P50705, P50707, P50708, P50713, P50714, Q30KJ3, Q30KJ7, Q30KK8, Q30KN4, Q30KP9, Q30KT5, Q32P86, Q32ZF7, Q32ZG2, Q32ZG3, Q32ZH2, Q32ZH6, Q3UW41, Q5DQQ6, Q5G865, Q5G866, Q5IAB9, Q5J602, Q6IE40, Q6IE41, Q6IV18, Q7Z7B8, Q8IUB3
Diamond homologs: A4H241, A4H253, A4H254, A4H255, Q30KP3, Q32ZH2, Q5J5Z9, Q7Z7B8, Q30KK1, Q9H1M4, A4H211, A4H212, A4H213, A4H235, A4H236, Q30KJ4, Q30KK5, Q30KL1, Q30KN8, Q30KP9, Q30KQ4, Q32ZG3, Q32ZG7, Q5IAB3, Q5J5D0, Q8K3U4, Q8N104, Q8N688
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
17 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 12 |
| Likely benign | 5 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
136 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:189000:T:TA | donor_gain | 0.9500 |
| 20:189636:C:A | donor_gain | 0.9300 |
| 20:189635:T:TA | donor_gain | 0.9100 |
| 20:188125:A:C | acceptor_gain | 0.8800 |
| 20:189625:T:C | donor_gain | 0.8800 |
| 20:189629:CAGA:C | donor_gain | 0.8400 |
| 20:188119:C:CC | acceptor_gain | 0.8000 |
| 20:189573:A:C | donor_loss | 0.7400 |
| 20:189574:C:G | donor_loss | 0.7400 |
| 20:188114:CCCGT:C | acceptor_gain | 0.7000 |
| 20:188115:CCGTC:C | acceptor_gain | 0.7000 |
| 20:188121:G:C | acceptor_gain | 0.7000 |
| 20:189580:A:AC | donor_gain | 0.7000 |
| 20:189026:A:AC | donor_gain | 0.6800 |
| 20:189027:C:CC | donor_gain | 0.6800 |
| 20:189085:ACATC:A | acceptor_gain | 0.6800 |
| 20:188115:CCGT:C | acceptor_gain | 0.6700 |
| 20:188116:CGT:C | acceptor_gain | 0.6700 |
| 20:188116:CGTC:C | acceptor_gain | 0.6700 |
| 20:188125:A:AC | acceptor_gain | 0.6600 |
| 20:188991:ATG:A | donor_gain | 0.6100 |
| 20:189573:ACCT:A | donor_gain | 0.5500 |
| 20:188118:TCTGT:T | acceptor_loss | 0.5400 |
| 20:188119:CTGT:C | acceptor_loss | 0.5400 |
| 20:188120:T:G | acceptor_loss | 0.5400 |
| 20:188124:C:CT | acceptor_gain | 0.5400 |
| 20:189019:AACT:A | donor_gain | 0.5300 |
| 20:189022:T:TA | donor_gain | 0.5300 |
| 20:189086:C:A | acceptor_gain | 0.5300 |
| 20:189572:TACC:T | donor_gain | 0.5300 |
AlphaMissense
605 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:188061:C:G | C36S | 0.975 |
| 20:188062:A:T | C36S | 0.975 |
| 20:188073:C:G | C32S | 0.964 |
| 20:188074:A:T | C32S | 0.964 |
| 20:188010:C:G | C53S | 0.963 |
| 20:188011:A:T | C53S | 0.963 |
| 20:188031:C:G | C46S | 0.962 |
| 20:188032:A:T | C46S | 0.962 |
| 20:188032:A:G | C46R | 0.957 |
| 20:188062:A:G | C36R | 0.956 |
| 20:188097:C:G | C24S | 0.955 |
| 20:188098:A:T | C24S | 0.955 |
| 20:188013:C:G | C52S | 0.953 |
| 20:188014:A:T | C52S | 0.953 |
| 20:188098:A:G | C24R | 0.946 |
| 20:188049:T:A | E40V | 0.933 |
| 20:188010:C:T | C53Y | 0.930 |
| 20:188009:A:C | C53W | 0.926 |
| 20:188074:A:G | C32R | 0.926 |
| 20:188069:C:A | R33S | 0.925 |
| 20:188069:C:G | R33S | 0.925 |
| 20:188073:C:T | C32Y | 0.925 |
| 20:188096:G:C | C24W | 0.923 |
| 20:188061:C:T | C36Y | 0.921 |
| 20:188011:A:G | C53R | 0.920 |
| 20:188072:G:C | C32W | 0.919 |
| 20:188030:A:C | C46W | 0.917 |
| 20:188049:T:G | E40A | 0.916 |
| 20:188061:C:A | C36F | 0.914 |
| 20:188060:G:C | C36W | 0.912 |
dbSNP variants (sampled 300 via entrez): RS1000418863 (20:188889 A>G), RS1000669041 (20:191422 C>T), RS1000753350 (20:190096 T>C), RS1000816591 (20:189129 G>A), RS1001585664 (20:190082 T>A), RS1002422946 (20:191021 C>G,T), RS1002594533 (20:187623 C>A), RS1002793353 (20:188637 A>C,G), RS1003054860 (20:187401 A>G), RS1003595555 (20:187572 A>G), RS1004022920 (20:191540 G>A), RS1004413080 (20:190997 T>C), RS1004867908 (20:190805 C>T), RS1006261899 (20:188592 C>T), RS1006595469 (20:189695 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001762_918 | Obesity-related traits | 7.000000e-07 |
| GCST007010_4 | Logical memory (delayed recall) | 6.000000e-07 |
| GCST007011_4 | Logical memory (immediate recall) | 3.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004874 | memory performance |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
1 total (human), top 1 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.